← Oncology Approval Tracker

FDA DECISION ·

Nilotinib capsules (later Nilecya)

nilotinib · Cipla

FDA approvalNew formulationChronic myeloid leukemia
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

For adults with newly diagnosed chronic-phase Philadelphia chromosome-positive CML, or chronic- or accelerated-phase disease resistant or intolerant to previous treatment that included imatinib.

LAMPGEN ANALYSIS

Why it matters

This original 505(b)(2) approval adds a separately approved nilotinib capsule product with adult CML indications.

What research teams should watch

Verify the exact capsule product and fasted administration instructions; maintain ECG, electrolyte, and interaction checks.

PRIMARY RECORDS

Sources